Vincerx Pharma, Inc. Profile Avatar - Palmy Investing

Vincerx Pharma, Inc.

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibit…

Biotechnology
US, Palo Alto [HQ]

Resulting Ratios

5 Records · Starting from 2019
Loading...
End of VINC's Analysis
CIK: 1796129 CUSIP: 92731L106 ISIN: US92731L1061 LEI: - UEI: -
Secondary Listings
VINC has no secondary listings inside our databases.